191 related articles for article (PubMed ID: 10770278)
1. The beta-thromboglobulins and platelet factor 4: blood platelet-derived CXC chemokines with divergent roles in early neutrophil regulation.
Brandt E; Petersen F; Ludwig A; Ehlert JE; Bock L; Flad HD
J Leukoc Biol; 2000 Apr; 67(4):471-8. PubMed ID: 10770278
[TBL] [Abstract][Full Text] [Related]
2. Down-regulation of neutrophil functions by the ELR(+) CXC chemokine platelet basic protein.
Ehlert JE; Ludwig A; Grimm TA; Lindner B; Flad HD; Brandt E
Blood; 2000 Nov; 96(9):2965-72. PubMed ID: 11049972
[TBL] [Abstract][Full Text] [Related]
3. Platelet-derived chemokines CXC chemokine ligand (CXCL)7, connective tissue-activating peptide III, and CXCL4 differentially affect and cross-regulate neutrophil adhesion and transendothelial migration.
Schenk BI; Petersen F; Flad HD; Brandt E
J Immunol; 2002 Sep; 169(5):2602-10. PubMed ID: 12193731
[TBL] [Abstract][Full Text] [Related]
4. Effects of the neutrophil-activating peptide NAP-2, platelet basic protein, connective tissue-activating peptide III and platelet factor 4 on human neutrophils.
Walz A; Dewald B; von Tscharner V; Baggiolini M
J Exp Med; 1989 Nov; 170(5):1745-50. PubMed ID: 2681518
[TBL] [Abstract][Full Text] [Related]
5. Novel C-terminally truncated isoforms of the CXC chemokine beta-thromboglobulin and their impact on neutrophil functions.
Ehlert JE; Gerdes J; Flad HD; Brandt E
J Immunol; 1998 Nov; 161(9):4975-82. PubMed ID: 9794434
[TBL] [Abstract][Full Text] [Related]
6. Platelet-derived CXC chemokines: old players in new games.
Brandt E; Ludwig A; Petersen F; Flad HD
Immunol Rev; 2000 Oct; 177():204-16. PubMed ID: 11138777
[TBL] [Abstract][Full Text] [Related]
7. Connective tissue-activating peptide III desensitizes chemokine receptors on neutrophils. Requirement for proteolytic formation of the neutrophil-activating peptide 2.
Härter L; Petersen F; Flad HD; Brandt E
J Immunol; 1994 Dec; 153(12):5698-708. PubMed ID: 7989767
[TBL] [Abstract][Full Text] [Related]
8. Formation of neutrophil-activating peptide 2 from platelet-derived connective-tissue-activating peptide III by different tissue proteinases.
Car BD; Baggiolini M; Walz A
Biochem J; 1991 May; 275 ( Pt 3)(Pt 3):581-4. PubMed ID: 2039437
[TBL] [Abstract][Full Text] [Related]
9. Structural requirements of platelet chemokines for neutrophil activation.
Yan Z; Zhang J; Holt JC; Stewart GJ; Niewiarowski S; Poncz M
Blood; 1994 Oct; 84(7):2329-39. PubMed ID: 7919350
[TBL] [Abstract][Full Text] [Related]
10. The CXC chemokine NAP-2 mediates differential heterologous desensitization of neutrophil effector functions elicited by platelet-activating factor.
Schwartzkopff F; Brandt E; Petersen F; Flad HD; Bock L; Ludwig A
J Interferon Cytokine Res; 2002 Feb; 22(2):257-67. PubMed ID: 11911809
[TBL] [Abstract][Full Text] [Related]
11. Mast cells and neutrophils proteolytically activate chemokine precursor CTAP-III and are subject to counterregulation by PF-4 through inhibition of chymase and cathepsin G.
Schiemann F; Grimm TA; Hoch J; Gross R; Lindner B; Petersen F; Bulfone-Paus S; Brandt E
Blood; 2006 Mar; 107(6):2234-42. PubMed ID: 16317101
[TBL] [Abstract][Full Text] [Related]
12. Neutrophils can generate their activator neutrophil-activating peptide 2 by proteolytic cleavage of platelet-derived connective tissue-activating peptide III.
Brandt E; Van Damme J; Flad HD
Cytokine; 1991 Jul; 3(4):311-21. PubMed ID: 1873479
[TBL] [Abstract][Full Text] [Related]
13. Chemotactic activity and receptor binding of neutrophil attractant/activation protein-1 (NAP-1) and structurally related host defense cytokines: interaction of NAP-2 with the NAP-1 receptor.
Leonard EJ; Yoshimura T; Rot A; Noer K; Walz A; Baggiolini M; Walz DA; Goetzl EJ; Castor CW
J Leukoc Biol; 1991 Mar; 49(3):258-65. PubMed ID: 1997632
[TBL] [Abstract][Full Text] [Related]
14. The amino-terminal residues in the crystal structure of connective tissue activating peptide-III (des10) block the ELR chemotactic sequence.
Malkowski MG; Lazar JB; Johnson PH; Edwards BF
J Mol Biol; 1997 Feb; 266(2):367-80. PubMed ID: 9047370
[TBL] [Abstract][Full Text] [Related]
15. Molecular cloning and characterisation of a neutrophil chemotactic protein from porcine platelets.
Power CA; Proudfoot AE; Magnenat E; Bacon KB; Wells TN
Eur J Biochem; 1994 Apr; 221(2):713-9. PubMed ID: 7513641
[TBL] [Abstract][Full Text] [Related]
16. Isolation, characterization, and immunological detection of neutrophil-activating peptide 2: a proteolytic degradation product of platelet basic protein.
Holt JC; Yan ZQ; Lu WQ; Stewart GJ; Niewiarowski S
Proc Soc Exp Biol Med; 1992 Feb; 199(2):171-7. PubMed ID: 1531540
[TBL] [Abstract][Full Text] [Related]
17. Thrombin-activated human platelets release two NAP-2 variants that stimulate polymorphonuclear leukocytes.
Piccardoni P; Evangelista V; Piccoli A; de Gaetano G; Walz A; Cerletti C
Thromb Haemost; 1996 Nov; 76(5):780-5. PubMed ID: 8950790
[TBL] [Abstract][Full Text] [Related]
18. Relationship between neutrophil-binding affinity and suitability for infection imaging: comparison of (99m)Tc-labeled NAP-2 (CXCL-7) and 3 C-terminally truncated isoforms.
Rennen HJ; Frielink C; Brandt E; Zaat SA; Boerman OC; Oyen WJ; Corstens FH
J Nucl Med; 2004 Jul; 45(7):1217-23. PubMed ID: 15235069
[TBL] [Abstract][Full Text] [Related]
19. Structure and bioactivity of recombinant human CTAP-III and NAP-2.
Proudfoot AE; Peitsch MC; Power CA; Allet B; Mermod JJ; Bacon K; Wells TN
J Protein Chem; 1997 Jan; 16(1):37-49. PubMed ID: 9055206
[TBL] [Abstract][Full Text] [Related]
20. Generation of the neutrophil-activating peptide NAP-2 from platelet basic protein or connective tissue-activating peptide III through monocyte proteases.
Walz A; Baggiolini M
J Exp Med; 1990 Feb; 171(2):449-54. PubMed ID: 2406364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
